CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Huntington, WV

Marshall University Pediatrics Cabell Huntington Hospital 1340 Hal Greeg Blvd, Huntington

This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.

HCC GR 45 – Tucson, AZ

This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).

Hemophilia A – Rochester, MN

This case-based live activity will cover the treatment and management of patients with hemophilia A